GALD.SW Stock — Price, Charts & Analysis

GALDERMA GROUP N (GALD.SW) has a trailing P/E of 57.16x and a forward P/E of 31.13x. This places GALD.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

GALD.SW trades with 57.16x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether GALD.SW looks overvalued or undervalued.

GALD.SW's P/E of 57.16x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

GALD.SW's trailing EPS is CHF 2.96 and forward EPS is CHF 5.43. Reported earnings growth is 130.70%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit GALDERMA GROUP N generated for each share. GALD.SW's trailing EPS is CHF 2.96, and investors usually prefer EPS that is positive and growing over time.

GALDERMA GROUP N has a market cap of CHF 39.46B, making GALD.SW a large-cap stock based on the current market value shown on Worldtickers.

GALD.SW's latest stock price on Worldtickers is CHF 169.20. The latest move is -CHF 1.75 or -1.02%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

GALD.SW's quote includes a latest price of CHF 169.20. The market open is CHF 171.60. Previous close is CHF 170.95. The intraday range is CHF 168.50 to CHF 172.70.

GALD.SW is down in the latest quote, with a move of -CHF 1.75 or -1.02%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

GALD.SW generated CHF 5.92B in trailing revenue. Revenue growth is 27.70%, which helps show whether demand is expanding or slowing.

GALD.SW's revenue growth is 27.70%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, GALD.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 863.00M.

Gross margin is 69.37%. Margins show how efficiently GALDERMA GROUP N turns revenue into profit.

GALDERMA GROUP N carries CHF 2.72B and holds CHF 839.00M in cash.

GALD.SW holds CHF 839.00M on its balance sheet.

GALD.SW's book value per share is CHF 28.62.

Yes, GALDERMA GROUP N pays a dividend of CHF 0.35 per share annually. The dividend yield is 20.00%. The payout ratio is 12.12%.

GALD.SW's dividend yield is 20.00%. Its payout ratio is 12.12%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for GALD.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through GALDERMA GROUP N's investor relations materials.

Institutions hold 48.19% of GALD.SW shares. Insiders hold 21.02% of shares. Ownership mix helps investors understand how much of GALDERMA GROUP N is held by professional investors and company insiders.

GALD.SW has 233.19M shares outstanding. Float shares are 131.27M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for GALD.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for GALD.SW is CHF 5.43. Earnings growth is 130.70%. Revenue growth is 27.70%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

GALD.SW's trailing EPS is CHF 2.96. Forward EPS is CHF 5.43. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

GALD.SW is in the Healthcare sector. Its earnings multiple is 57.16x. Its latest displayed growth metric is 27.70%. Compare these figures with sector peers before deciding whether GALDERMA GROUP N is stronger or weaker than average.

GALD.SW trades at CHF 169.20. The stock trades at 57.16x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of GALDERMA GROUP N's fundamentals.

GALD.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -0.10, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

GALD.SW should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 57.16x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

GALDERMA GROUP N (GALD.SW) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology.

GALD.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

GALD.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

GALDERMA GROUP N's official website listed on Worldtickers is www.galderma.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

GALDERMA GROUP N employs about 7.68K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

GALDERMA GROUP N is headquartered in Zug, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

GALD.SW is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

GALD.SW has traded between CHF 130.20 and CHF 188.25 over the past 52 weeks. At CHF 169.20, it is 10.12% below the high and 29.95% above the low. The 52-week range helps gauge long-term price momentum.

GALD.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is CHF 175.02 and its 200-day moving average is CHF 159.96.

GALD.SW's RSI is 44.46. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

GALD.SW's latest RSI reading is 44.46, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for GALD.SW is near CHF 166.65. Key resistance is near CHF 184.00. Breaks above resistance or below support can change the short-term technical setup.

GALD.SW's nearest reported support level is CHF 166.65. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

GALD.SW's nearest reported resistance level is CHF 184.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

GALD.SW trades about 434.69K shares daily on average. The latest displayed volume is 312.83K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

GALD.SW's MACD is -0.94, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

GALD.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 44.46 (neutral). MACD is bearish. Nearest support is around CHF 166.65. Resistance is around CHF 184.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 175.16 (-2.40% from price). MA50 is CHF 175.02 (-2.33% from price). MA200 is CHF 159.96 (6.87% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. GALD.SW's MA20 is CHF 175.16. MA50 is CHF 175.02. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

GALD.SW's pivot is near CHF 168.62. Support is near CHF 166.65. Resistance is near CHF 184.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for GALD.SW is near CHF 160.83. The next upper resistance zone is near CHF 176.55. These levels help define risk and possible follow-through zones after a breakout or breakdown.

GALD.SW's Bollinger range is roughly CHF 168.25 to CHF 182.07. Band width is near 7.89%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

GALD.SW's ATR-based typical daily range is about 2.97%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 312.83K shares. Average volume is about 434.69K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

GALD.SW's all-time high shown on Worldtickers is CHF 188.25. Its all-time low is CHF 53.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

GALD.SW has a beta of -0.10, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.